Characterization of molecular and cellular functions of the cyclin‐dependent kinase <scp>CDK9</scp> using a novel specific inhibitor

Our study provides a framework for the mechanistic understanding of cellular responses to CDK9 inhibition. LDC000067 represents a promising lead for the development of clinically useful, highly specific CDK9 inhibitors.